Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Antiaging Quantum Living (AAQL) Common Equity (2020 - 2025)

Antiaging Quantum Living (AAQL) has disclosed Common Equity for 6 consecutive years, with -$300616.0 as the latest value for Q4 2025.

  • Quarterly Common Equity fell 131.79% to -$300616.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$300616.0 through Dec 2025, down 131.79% year-over-year, with the annual reading at -$1.1 million for FY2025, 173.5% down from the prior year.
  • Common Equity hit -$300616.0 in Q4 2025 for Antiaging Quantum Living, up from -$1.3 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $945553.0 in Q4 2024 to a low of -$1.3 million in Q3 2025.
  • Historically, Common Equity has averaged -$295872.5 across 5 years, with a median of -$78874.0 in 2022.
  • Biggest five-year swings in Common Equity: plummeted 5856.28% in 2021 and later soared 711.06% in 2024.
  • Year by year, Common Equity stood at -$45820.0 in 2021, then tumbled by 72.14% to -$78874.0 in 2022, then crashed by 96.19% to -$154741.0 in 2023, then skyrocketed by 711.06% to $945553.0 in 2024, then tumbled by 131.79% to -$300616.0 in 2025.
  • Business Quant data shows Common Equity for AAQL at -$300616.0 in Q4 2025, -$1.3 million in Q3 2025, and -$1.3 million in Q2 2025.